Jeffrey J. Tosoian MD, MPHAssistant Professor of Urology, Vanderbilt University Medical Center and Vanderbilt-Ingram Cancer Center, Nashville, TN
Jeffrey J. Tosoian, MD, MPH, is an Assistant Professor of Urology at the Vanderbilt University Medical Center and Vanderbilt-Ingram Cancer Center. He completed medical school and urology residency at Johns Hopkins, where he obtained an MPH in epidemiological and biostatistical methods for clinical research. He then completed a translational research and clinical fellowship in urologic oncology at the University of Michigan. Dr. Tosoian’s research is focused on the development and clinical application of diagnostic and prognostic tools, including blood-, urine-, and tissue-based biomarkers, to guide detection and management of genitourinary cancers.
Dr. Tosoian is a co-founder of LynxDx, Inc.
Recent Contributions to PracticeUpdate:
- Multiparametric MRI-Ultrasound Fusion Targeted Prostate Biopsy Combined With Standard Template Improves Prostate Cancer Detection
- Systematic vs Targeted MRI/Ultrasound Fusion Prostate Biopsy Among Men With Visible Lesions
- Risk of Adverse Pathology at Prostatectomy in the Era of MRI and Targeted Biopsies
- Pathologic Upgrading in Favorable Intermediate Risk Active Surveillance Patients
- Optimal Management of a Man With Recurrent Prostate Cancer
- African American Men and Low-Risk Prostate Cancer Outcomes
- Widely Metastatic Prostate Cancer at Diagnosis
- How Often Should You Meet With Your Mentor(s)?
- What Makes a Good Mentor?
- Getting into a Competitive Fellowship Program – Approaches